Therapeutic effects of glatiramer acetate and grafted CD115+monocytes in a mouse model of Alzheimer’s disease

Cited by (152)

Items 101–152 of 152

  1. Fighting fire with fire: The immune system might be key in our fight against Alzheimer’s disease
    Pieter Dujardin, Roosmarijn E. Vandenbroucke, Lien Van Hoecke · 2022 · Drug Discovery Today
  2. Neuronal–Glial Interaction in a Triple-Transgenic Mouse Model of Alzheimer’s Disease: Gene Ontology and Lithium Pathways
    Nicole Kemberly Ribeiro Rocha, Rafael Martins Themoteo, Helena Brentani, Orestes Vicente Forlenza, Vanessa de Jesus Rodrigues de Paula · 2020 · Frontiers in Neuroscience
  3. The vicious cycle governing the brain–immune system relationship in neurodegenerative diseases
    Michal Schwartz, Liora Cahalon · 2022 · Current Opinion in Immunology
  4. Boosting peripheral immunity to fight neurodegeneration in the brain
    Michal Schwartz, Sarah Phoebeluc Colaiuta · 2024 · Trends in Immunology
  5. Engineering blood–brain barrier microphysiological systems to model Alzheimer's disease monocyte penetration and infiltration
    Longjun Gu, Xiangdi Mao, Chunhui Tian, Yang Yang, Kaiyuan Yang, Scott Glen Canfield, Donghui Zhu, Mingxia Gu, Feng Guo · 2025 · Biomaterials Science
  6. Contextualizing the Role of Osteopontin in the Inflammatory Responses of Alzheimer’s Disease
    Roshni C. Lalwani, Claude‐Henry Volmar, Claes Wahlestedt, Keith A. Webster, Lina A. Shehadeh · 2023 · Biomedicines
  7. Immune cells in Alzheimer’s disease: insights into pathogenesis and potential therapeutic targets
    Xiaofeng Fu, Huimin Cai, Shuiyue Quan, Ziye Ren, Yuyun Xu, Longfei Jia · 2024 · Medical Review
  8. Administration of anti-ERMAP antibody ameliorates Alzheimer’s disease in mice
    Haiyan Liu, Jin Xia Zhao, Yujun Lin, Min Su, Laijun Lai · 2021 · Journal of Neuroinflammation
  9. Aβ and Inflammatory Stimulus Activate Diverse Signaling Pathways in Monocytic Cells: Implications in Retaining Phagocytosis in Aβ-Laden Environment
    Ekaterina Savchenko, Tarja Malm, Henna Konttinen, Riikka H. Hämäläinen, Cindy Guerrero-Toro, Sara Wojciechowski, Rashid A. Giniatullin, Jari Koıstınaho, Johanna M. Magga · 2016 · Frontiers in Cellular Neuroscience
  10. Mutant mice with rod-specific VPS35 deletion exhibit retinal α-synuclein pathology-associated degeneration
    Cheng Fu, Nan Yang, Jen-Zen Chuang, Nobuyuki Nakajima, Satoshi Iraha, Neeta Singh Roy, Zhenquan Wu, Zhichun Jiang, Wataru Otsu, Roxana A. Radu et al. · 2024 · Nature Communications
  11. Foveal Avascular Zone and Choroidal Thickness Are Decreased in Subjects with Hard Drusen and without High Genetic Risk of Developing Alzheimer’s Disease
    Inés López‐Cuenca, Rosa de Hoz, Celia Alcántara‐Rey, Elena Salobrar‐García, Lorena Elvira‐Hurtado, José A. Fernández‐Albarral, Ana Barabash, Federico Ramírez‐Toraño, Jaisalmer de Frutos‐Lucas, Juan Jose Salazar et al. · 2021 · Biomedicines
  12. Alzheimer's disease and the immune system: A comprehensive overview with a focus on B cells, humoral immunity, and immunotherapy
    Ladan Gol Mohammad Pour Afrakoti, Sanam Daneshpour Moghadam, Pezhman Hadinezhad · 2025 · Journal of Alzheimer s Disease Reports
  13. CD206+/MHCII− macrophage accumulation at nerve injury site correlates with attenuation of allodynia in TASTPM mouse model of Alzheimer's disease
    Rita Silva, George Sideris-Lampretsas, Sarah Fox, Lynda Zeboudj, Marzia Malcangio · 2022 · Brain Behavior & Immunity - Health
  14. Immunization with Neural-Derived Peptides in Neurodegenerative Diseases: A Narrative Review
    Germán Rivera Monroy, Renata Murguiondo Pérez, Efraín Weintraub Ben-Zión, Oscar Alcantar-Garibay, Ericka Cristina Loza-López, Emilio Tejerina Marion, Enrique Blancarte-Hernández, Lisset Karina Navarro-Torres, Antonio Ibarra · 2023 · Biomedicines
  15. Interleukin-4 promotes the clearance of amyloid-β by monocyte through enhancing the recognition and intracellular processing of amyloid-β
    Sihan Chen, Yuan Cheng, Yan‐Jiang Wang, Yi-Fei Ji · 2024 · Journal of Alzheimer s Disease
  16. The Role of T Cells in Alzheimer's Disease Pathogenesis
    Jin Zhao, Xiaofang Wang, Yusheng He, Pingyi Xu, Laijun Lai, Younggie Chung, Xinghua Pan · 2023 · Critical Reviews in Immunology
  17. The effects of high plasma levels of Aβ1-42 on mononuclear macrophage in mouse models of Alzheimer’s disease
    Chunrong Li, Kangding Liu, Jie Zhu, Feiqi Zhu · 2023 · Immunity & Ageing
  18. Assessing the In Vitro Potential of Glatiramer Acetate (Copaxone®) as a Chemotherapeutic Candidate for the Treatment of Cryptococcus neoformans Infection
    Vinícius Alves, Pedro Martins, Bruna Porpino Miranda, Iara Bastos de Andrade, Luiza Pereira, Christina Takiya Maeda, Glauber Ribeiro de Sousa Araújo, Susana Frasés · 2023 · Journal of Fungi
  19. Treatment with glatiramer acetate in APPswe/PS1dE9 mice at an early stage of Alzheimer’s disease prior to amyloid-beta deposition delays the disease’s pathological development and ameliorates cognitive decline
    Zengyong Huang, Zhuo Gong, Yongtai Lin, Fan Yang, Weiping Chen, Shaotong Xiang, Yuedong Huang, Hao Xiao, Shuwen Xu, Jinhai Duan · 2024 · Frontiers in Aging Neuroscience
  20. Quantifying miRNA Deregulation in Alzheimer’s Disease
    Ana Luísa Cardoso, Joana Ribeiro Guedes · 2018 · Methods in molecular biology
  21. Alzheimer’s disease causes bone marrow myelopoiesis dysfunction
    Miguel Angel Abellanas, Leyre Basurco, Maitreyee Purnapatre, Chiara Burgaletto, Giulia Castellani, Sarah Phoebeluc Colaiuta, Javier María Peralta Ramos, Angham Ibraheem, Sama Murad, Paola Antonello et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  22. Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer’s Disease
    Berke Karaahmet, John A. Olschowka, M. Kerry O’Banion · 2023 · Pharmaceutics
  23. Correlation between Blood Monocytes and CSF Tau in Alzheimer’s Disease: The Effect of Gender and Cognitive Decline
    Carlotta Ginevra Valentina Cimiotti, Paolo Paganetti, Stefania Rossi, Emiliano Soldini, Leonardo Sacco · 2023 · NeuroSci
  24. Advances in Retinal Imaging: Retinal Amyloid Imaging
    Maya Koronyo‐Hamaoui, Jonah Doustar, Mia Oviatt, Keith L. Black, Yosef Koronyo · 2020 · Springer eBooks
  25. Targeting glial PD-1/PD-L1 restores microglial homeostasis and attenuates neuronal hyperactivity in an Alzheimer’s disease model
    Taeyoung Park, Leechung Chang, Seung Won Chung, Seowoo Lee, Sungjun Bae, Carlo Condello, Yong Ho Kim, Jaecheol Lee, Han-Joo Kim, Ho-Keun Kwon et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  26. Therapeutic effect of systemic use of glatiramer acetate in imiquimod-induced mouse psoriasis model
    Goknur Demiran, Rukiye Yasak Güner, Mustafa Ozkara, Mustafa Tosun, Melih Akyol · 2025 · Cutaneous and Ocular Toxicology
  27. Contribution of “Genuine Microglia” to Alzheimer's Disease Pathology
    Sadayuki Hashioka, Ken Inoue, Koji Otsuki, Maiko Hayashida, Rei Wake, Noriyuki Kawano, Haruo Takeshita, Masatoshi Inagaki · 2022 · Frontiers in Aging Neuroscience
  28. Systemic inflammation in relation to exceptional memory in the Long Life Family Study (LLFS)
    Ruhee A. Patel, Stephanie Cosentino, Esther Zhiwei Zheng, Nicole Schupf, Sandra Barral, Mary Furlan Feitosa, Stacy L. Andersen, Paola Sebastiani B, Svetlana V. Ukraintseva, Kaare Christensen et al. · 2024 · Brain Behavior & Immunity - Health
  29. The Expression of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) in Hippocampal Arterioles Declines During Progression of Alzheimer’s Disease
    Kelley E. Anderson, Thomas A. Bellio, Emily Aniskovich, Stephanie L. Adams, Jan Krzysztof Blusztajn, Ivana Delalle · 2020 · Cerebral Cortex Communications
  30. Fighting Chronic Neuroinflammation by Boosting Autoimmunity
    Michal Schwartz, Kuti Baruch · 2016 · Elsevier eBooks
  31. Influence of lithium in neuron-glia interaction in hippocampal neurons
    Nicole Kemberly Ribeiro Rocha, Orestes Vicente Forlenza, Daniel S. Kerr, Helena Brentani, Vanessa de Jesus Rodrigues de Paula · 2018 · Revista de Medicina
  32. Neuroprotective and Neurorestorative Properties of Copolymer-1: Its Immunomodulating Effects on Ischemic Stroke
    Yolanda Cruz, Melanie Tessa Saavedra Navarrete, José Juan Antonio Ibarra Arias · 2020 · IntechOpen eBooks
  33. Glia maturation factor-γ regulates amyloid-β42 phagocytosis through scavenger receptor class A type I in murine macrophages
    Wulin Aerbajinai, Jianqiong Zhu, Kyung Chin, Griffin P. Rodgers · 2024 · Journal of Leukocyte Biology
  34. Epigenetic derepression of H3K9me3 mitigates Alzheimer-related pathology and improves cognition via immunomodulation and Vgf induction
    Dieu-Trang S. Fuchs, Jean‐Philippe Vit, Altan Rentsendorj, Julia Sheyn, Haoshen Shi, Yosef Koronyo, Oksana M. Chepurna, Miyah R. Davis, Jered W. Wilson, Lon S. S. Schneider et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  35. Early-Life Systemic Inflammation Modulate Microglia Phenotype to Slow Down Aβ Pathology in the 5xFAD Mouse Model of Alzheimer’s Disease
    Yiyi Yang, Marta García-Cruzado, Hairuo Zeng, Xinrui Wang, Sara Bachiller, Lluís Camprubí-Ferrer, Bazhena Bahatyrevich-Kharitonik, Rosalía Fernández‐Calle, Tomas Deierborg · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Molecular mechanism decipher of Alzheimer’s disease based on single-cell RNA-seq information
    Xue Jiang, Dong-Qing Wei, Jing Ye, Éric Gilson · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Additional file 5 of Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
    Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, Sharon, Efrat, Giulia Castellani, Shir Ferrera, Liora Cahalon, Sarah Phoebeluc Colaiuta, Salame, Tomer-Meir, Schwartz, Michal · 2021 · Figshare
  38. Additional file 3 of Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
    Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, Sharon, Efrat, Giulia Castellani, Shir Ferrera, Liora Cahalon, Sarah Phoebeluc Colaiuta, Salame, Tomer-Meir, Schwartz, Michal · 2021 · Figshare
  39. Additional file 4 of Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
    Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, Sharon, Efrat, Giulia Castellani, Shir Ferrera, Liora Cahalon, Sarah Phoebeluc Colaiuta, Salame, Tomer-Meir, Schwartz, Michal · 2021 · Figshare
  40. Additional file 2 of Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
    Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, Sharon, Efrat, Giulia Castellani, Shir Ferrera, Liora Cahalon, Sarah Phoebeluc Colaiuta, Salame, Tomer-Meir, Schwartz, Michal · 2021 · Figshare
  41. Additional file 1 of Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
    Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, Sharon, Efrat, Giulia Castellani, Shir Ferrera, Liora Cahalon, Sarah Phoebeluc Colaiuta, Salame, Tomer-Meir, Schwartz, Michal · 2021 · Figshare
  42. Additional file 6 of Key role of the CCR2-CCL2 axis in disease modification in a mouse model of tauopathy
    Hila Ben-Yehuda, Michal Arad, Javier María Peralta Ramos, Sharon, Efrat, Giulia Castellani, Shir Ferrera, Liora Cahalon, Sarah Phoebeluc Colaiuta, Salame, Tomer-Meir, Schwartz, Michal · 2021 · Figshare
  43. Memantine mitigates radiation-induced cognitive impairment by modulating AKT/GSK3β signaling
    Hao Fu, J. H. Feng, Xiaohong Zhang, Liuxin Tian, Simin Sun, Hongyu Bo, Chengyu He, Xu Wang · 2026 · Radiation and Environmental Biophysics
  44. H3K9me3 inhibition reverses Alzheimer′s progression by restoring synaptic and immune proteostasis across the brain–retina axis
    Maya Koronyo‐Hamaoui, Dieu-Trang S. Fuchs, Jean‐Philippe Vit, Altan Rentsendorj, Yosef Koronyo, Julia Sheyn, Bhakta Prasad Gaire, Saba Shahin, Haoshen Shi, Oksana M. Chepurna et al. · 2026 · Research Square
  45. Rôle de la neuroinflammation et du récepteur microglial TREM2 dans la progression de deux modèles de tauopathie
    Audrey Vautheny · 2019 · theses.fr (ABES)
  46. Nuclear accumulation of PANK4 in hippocampal astrocytes aggravates cuproptosis in association with mild cognitive impairment in aged mice
    Bo Wang, Jing Zhang, Chang-Hong Li, Xiao Huang, Ruo‐Bing Gao, Yan Peng, Qing Xie, Ya‐Lei Ning, Yan Zhao, Nan Yang et al. · 2026 · Frontiers in Aging Neuroscience
  47. Systemic association between aging and Alzheimer′s disease: From shared mechanisms to multi-target interventions
    Qiu Jiang, Yan-Jiang WANG · 2026 · Shengming kexue
  48. Early Retinal UCHL1 Dysregulation Coupled With Synaptic Loss Reflects Alzheimer's Disease Severity
    Altan Rentsendorj, Jean‐Philippe Vit, A. Hutton, Yosef Koronyo, Saba Shahin, Edward Robinson, Ernesto Barrón, Anthony Rodriguez, Ousman Jallow, Julia Sheyn et al. · 2026 · Advanced Science
  49. Bone marrow myelopoiesis dysfunction in Alzheimer’s disease limits monocyte homing to the brain and drives disease progression
    Miguel Angel Abellanas, Leyre Basurco, Maitreyee Purnapatre, Chiara Burgaletto, Giulia Castellani, Sarah Phoebeluc Colaiuta, Javier María Peralta Ramos, Angham Ibraheem, Sama Murad, Paola Antonello et al. · 2026 · Nature Neuroscience
  50. Targeting glial PD-1/PD-L1 restores microglial homeostasis and reduces neuronal hyperactivity in an Alzheimer’s disease model
    Taeyoung Park, Leechung Chang, Seung Won Chung, Seowoo Lee, Sungjun Bae, Carlo Condello, Yong Ho Kim, Jaecheol Lee, Han-Joo Kim, Ho‐Keun Kwon et al. · 2026 · Science Advances
  51. MAFG as a Redox‐Sensitive Node Linking Peripheral Immune Reprogramming to Cognitive Risk in the Sepsis‐to‐Alzheimer's Disease Continuum: Single‐Cell Dissection and Adoptive‐Transfer Validation
    Xiaoyu Xiang, Tingting Li, Zhongxue Feng, Jing Yang, Zhiwen Gong, Lietao Wang, Lijun Wang, Wei Zhang · 2026 · CNS Neuroscience & Therapeutics
  52. H3K9me3 inhibition reverses Alzheimer's progression by restoring synaptic and immune proteostasis across the brain–retina axis
    D. Fuchs, Jean-Philippe Vit, A. Rentsendorj, Yosef Koronyo, J. Sheyn, B. Gaire, Saba Shahin, Hao-Shen Shi, O. Chepurna, M. R. Davis et al. · 2026 · Alzheimer's & Dementia